industrywid risk remain top mind think
narrow moat prove durabl
updat forecast estim sep
busi strategi outlook
narrow moat stem domin essenti
posit within dialysi market account one
third dialysi facil patient treatment
much investor concern last year ultim
stem industri structur levi industrywid profit
small hand commerci insur patient caution
investor lose sight bigger pictur provid
lifesav healthcar servic chronic ill patient
low-cost outpati set sinc altern outpati
dialysi higher cost less effici burdensom acut
therapi see littl likelihood falter due regulatori
disrupt long term said think continu
scrutini patient assist program could caus near-term pain
industri propos legisl goe effect limit
patient abil continu commerci plan time
howev
consolid leav compar advantag posit
versu smaller independ peer lack cost advantag
present oper think investor need balanc
consider risk industri compel
volum growth
low-
would catalyz
valuat summari forecast
financi summari forecast
conduct analyst
govern code ethics/cod conduct
polici secur trade polici
equival invest research
interest visit
primari analyst cover compani
stock
research sep
estim sep
price data sep
rate updat sep
currenc amount express
busi strategi outlook
methodolog valu compani
put asid present concern industri take
favor view manag recent sale davita
medic group asset long drag profit return
capit busi perenni under-perform follow
acquisit absent major structur chang dialysi
reimburs polici anticip return capit
improv manag focus scale intern
presenc without distract dmg assess
manag capit alloc prowess somewhat
tarnish experi dmg plan use
billion proce larg debt reduct stepped-up share
repurchas like near immedi value-cr capit
historical/forecast data sourc morningstar estim may reflect adjust
davita inc largest provid dialysi servic boast
market share level eclips measur patient clinic
firm oper facil world-wide locat
unit state treat patient global year
manag began build fledgl intern busi
anticip busi need continu expand
garner scale need earn attract return govern payer
domin dialysi reimburs -- receiv approxim
 sale medicar medicaid reimburs rate
remain come commerci insur
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
rais fair valu estim per share
account time valu money along
modest updat assumpt valuat impli
time estim adjust earn
ebitda respect
forecast call growth domest
dialysi servic oper contempl treatment
growth near revenu per treatment
approxim five-year forecast horizon
volum assumpt impli modest share gain
period gain roughli basi point
share patient given matur
segment think increment margin gain difficult
come model less basi point total
margin expans forecast period importantli
assum materi profit impact on-going
concern regard premium assist across industri
california recent passag legisl limit
effect premium assist program put
assumpt question although think odd bill
get implement still air estim
consolid ebitda reduc roughli
worst-cas outcom california
firm intern dialysi busi estim
revenu growth nearer low- mid-teen rate
forecast period manag focus invest
segment driven double-digit growth total
number clinic oper annual price
improv averag time busi
gain scale estim meaning improv
profit break-even slightli profit level
forecast ebitda margin roughli
believ ampl room exist continu expans
matur level like low- mid-teen
although expos sizabl low-prob risk
view think share deserv medium
bull-cas scenario think firm consolid
revenu grow roughli approxim basi
point better base-cas estim help
treatment growth nearer better
price environ lead growth annual
per-treat price averag forecast period
addit aggress
intern market lead high-teen growth revenu
growth rate segment faster growth less
restrict price environ allow better-than-expect
margin perform estim nearli basi
point oper ebtida margin expans
firm domest dialysi segment bull-cas
assumpt lead consolid oper
margin roughli near histor high
busi incorpor assumpt result
fair valu estim per share time
higher estim earn ebitda
bear-cas assumpt result total compani revenu
growth nearer basi point lower
base-cas forecast case expect firm
oper grow treatment volum line total esrd
patient growth flat overal per-treat price
perpetu incorpor modest impact
propos chang patient access
ebitda forecast roughli lower base case
estim price pressur cost inflat combin
reduc dialysi margin approxim basi
point intern segment lower level
invest new facil cost pressur result
modest profit low singl digit
lead total compani oper margin
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
kidney transplant result dialysi industri
continu expand overal facil count build
capac keep pace patient growth
also improv conveni number
facil unit state stood roughli
approxim compound annual
growth rate period estim
par overal growth rate preval end-stag
renal diseas esrd case sinc
like mani healthcar provid coverag
govern payer medicar medicaid
repres largest payer nation unlik
compani coverag esrd diseas state
automat qualifi
medicar coverag
regardless patient age circumst specif
patient tradit commerci insur allow
earli enrol medicar month initi
environ make negoti commerci
payer vastli import tradit healthcar
provid explain dialysi servic becom
highli concentr
fragment seen area acut care
aggreg govern reimburs estim
industri level must extract commerci
insur earn roughli two third revenu
government-bas payer third
commercial-pay patient said estim patient
mix even lopsid roughli patient
base commerci insur medicar per
treatment base payment rate estim
commerci reimburs fall north
abil earn reimburs rate nearli
time govern will pay indic
substanti negoti leverag view
cost side equat industri benefit
histor low estim culmin fair valu
estim per share time lower
earn ebitda estim respect
believ peer freseniu medic
benefit scale-deriv cost advantag thank
domin global dialysi market combin
estim two entiti account greater
dialysi market unit state measur
either clinic oper patient treat level
scale provid per-unit cost advantag firm
along materi negoti power contract
commerci insur crucial sustain
earn excess return industri
treat patient unit state
current requir mainten
although home-bas treatment exist
gain margin share time in-cent treatment
gruel requir three center visit per week hour
rest patient life receiv
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
expect firm profil improv follow
divestitur davita medic group believ core
element underpin firm cost advantag within
dialysi remain stabl time estim
firm continu grow share unit state
expand facil base addit break-even
intern busi like contribut
enterpris time achiev relev scale davita
better abl leverag invest made
to-dat reimburs uncertainti unlik
fade given dynam industri think davita
retain posit low end cost curv
key reduc cost improv outcom
treatment esrd
scale high capac util accord medpac
lowest volum facil oper medicar cost
per treatment north highest volum
oper benefit cost closer
annual place estim averag cost medicar
patient somewher per treatment
help valid profit estim payer
suggest
medicar busi break-even best even largest
provid space freseniu oper
best-in-class util level help improv
unit econom -- two largest provid oper
roughli firm-wide capac averag versu
rest industri oper littl
view advantag two side scale
earn best-in-class reimburs
commerci insur also provid procur
effici support firm consist mid-teen
separ firm moat worthi dialysi franchis
process divest medic
group dmg busi unitedhealth group
close end year support
divestitur firm abl get favor
price asset billion versu billion paid
acquir think would deserv
no-moat rate best estim put dmg return
capit mid-single-digit rang declin
sinc initi bought busi think
addit asset one major factor
behind compani weaker return profil sinc
estim suggest return focu core dialysi
busi quickli improv futur return
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
benefit long-term tailwind
grow global esrd patient popul
preval diabet hypertens continu
market-lead posit ensur
benefit low-cost oper industri
becom increasingli hostil sub-scal provid
ounderpenetr intern market quickli
becom largest esrd market world
oper allow continu growth
owith except high relianc commerci
reimburs profit industri would
neg impact insur gain addit
flexibl move patient book onto
oalthough medicar rate updat trend
posit late recent net payment
updat like still overal cost inflat
experienc servic provid
ochang govern polici regard attitud
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
equival begin period
total avail debt servic
oblig commit
total oblig commit
adjust free
gener
gener revolv adjust
commit
think firm oper respons leverag
profil given high consist busi gross
debt level typic rang time adjust
ebitda follow divestitur dmg expect
manag alloc sizabl portion billion
cash proce toward debt reduct leav
leverag estim near time howev also note
leas nearli dialysi clinic creat
roughli billion estim reimburs
pressur pose acut risk dialysi provid unseen
elsewher healthcar provid sector given
industri relianc small segment overal esrd
patient popul maintain profit oper
remain key oper risk think
superior cost posit help insul advers
market condit compar smaller fragment
give medium uncertainti rate due
critic natur servic provid expand
patient popul firm concentr exposur
govern payer line peer unilater
reimburs pressur remain key risk
industri howev think firm substanti scale
ensur well posit mitig headwind
aris potenti reimburs cut reduc patient
coverag commerci insur time
face new risk potenti opportun expand
busi improv live patient broader
adopt comprehens care initi increas
quality-link payment penalti chang
busi model futur payment technolog
risk like gener headlin come year
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
hemodialysi primari treatment modal unlik
signific co-morbid within patient popul
skew older make widespread adopt home-bas
therapi difficult view said like gain
share margin technolog continu advanc
becom patient-friendli see
major risk core oper final
appeal court struck propos rulemak
center medicar medicaid servic relat
limit dialysi patient access premium assist
program recent propos legisl california
state threaten enact similar barrier patient
access rule go effect dialysi
industri would see profit suffer largest
player like continu consolid complet exit
market creat threat
profit near term believ superior cost
posit allow weather upcom storm
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
repres date owner name posit common share held report holder issuer
fidel manag research compani
share
fund
share
fund
give kent thiri rest manag team
davita standard mark capit stewardship
think team done except job develop
firm domin posit dialysi market
unit state think firm foray broader
purchas
healthcar partner rais red flag
year reimburs pressur leadership turnov
busi restructur happi see manag
sell busi nearli billion said fail
invest coordin care leav us skeptic
relat futur capit alloc manag intend
use cash windfal pay debt repurchas
share two use capit think benefit
sharehold long run given firm current market
manag invest prioriti without distract
dmg segment -- prefer see bulk
no-moat intern dialysi oper make
anoth attempt diversifi area healthcar
forward
fan compens structur put place
compani board believ well suit
hold manag account sharehold valu
creation manag annual bonu tie
clinic outcom oper incom
think critic measur success long-term
incent pay execut offic split
perform share time-bas award half tie
metric adjust earn rel total
sharehold return half subject
time-bas vest schedul said like see
insid ownership upper level manag
particularli given member long tenur firm --
whole director offic group less
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
california legisl threat neg manag
concern dialysi provid aug
california assembl surprisingli pass legisl
would reduc commerci reimburs rate dialysi
treatment par medicar payment patient
receiv premium assist primarili american
kidney fund bill still pass senat
sign gov jerri brown legisl
materi consequ freseniu medic
even plan leav fair valu
estim narrow moat rate compani
place success bill look assur
legisl clear neg dialysi provid
think there number potenti unintend
consequ bill might give govern
offici paus sign law assum reduc
commerci reimburs rate patient receiv
premium assist would hurt patient access newli
unprofit facil close provid reduc
financi support charit program without financi
assist specul affect popul would
probabl transit medicar medicaid effect
lead desir reduct provid reimburs
insur compani appear winner
legisl patient kick book
mani unhappi commerci patient state
medicaid budget hold lose hand patient shift
medicar lean medicaid supplement
mani unknown estim effect
dialysi compani profit would less
market initi impli face exposur
given service-focus busi california
repres close oper base
assumpt think bill pass would reduc
davita ebitda could partial off-set
cost-sav measur likelihood facil
upcom proposit ballot initi california
cap dialysi facil profit also face uncertain path
includ outcom vote complic
implement direct spend cost calcul
initi think imposit profit
cap facil level would increment neg
dialysi provid bulk impact would
address implement premium assist
bill said hesit handicap net effect
time given uncertain odd ballot outcom
dialysi oper track uncertain ballot
result within
expect plan keep fair valu estim
narrow moat rate place despit
on-going stabl perform dialysi oper --
includ healthi non-acquir treatment
growth adjust oper margin slightli
last year investor eye remain
upcom ballot initi california could cap
dialysi clinic profit state hesit handicap
intrins valu limit exposur
california unknown odd initi likelihood
pass uncertainti actual implement
allow cost defin polici
estim oper profit impact would
probabl reach unfavor outcom without
offset initi base increas tax rate
year-end guidanc nondeduct advocaci cost
estim spend near million next
month quash california ballot initi along
similar propos state like ohio
outsid ballot initi issu think davita
dialysi busi sustain stabl result despit
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
manag note mostli neutral effect medicar
part reimburs calcimimet parsabiv versu
previou payment drug paid part
seem face fewer issu
reimburs shift peer freseniu there
potenti investor concern ballot initi
facil staf requir state like california
think dialysi compani model alreadi account
on-going reimburs oper cost pressur
industri even though passag legisl
potenti financi effect difficult quantifi time
commerci rate pressur seen year
on-going shift reimburs calcimimet
parsabiv posit propos increas
medicar renal diseas reimburs rate fiscal
reflect signific improv flat rate
wit last year addit davita
plan outsourc pharmaci busi follow
diminish econom portion busi
manag anticip oper
loss
prescript busi back half year
transit process mostli off-set recoveri
revenu primarili bad debt occur
post first quarter expect
dont anticip chang fair valu estim
compani first-quart result mostli
match expect manag year-end outlook
remain unchang appear achiev thank
mostli stabl perform dialysi oper
still anticip sale medic group segment formerli
healthcar partner close year view sale
posit firm narrow econom moat thank
reimburs pressur limit competit advantag
busi still anticip larg portion
sale proce util share repurchas
treatment growth
oper margin quarter align
reimburs pressur
account chang alreadi anticip margin
pressur year adjust oper margin
basi point year-ago period
rise labor cost remain concern industri
manag held total cost per treatment growth
increas revenu per treatment
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
financi summari forecast
fiscal year end decemb
earn interest tax
return asset
return equiti
valuat summari forecast
equiti
pre-tax debt
weight averag capit
addit estim scenario avail download http //select morningstar com
equival
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
page
data tabl repres base-cas forecast compani report
currenc begin current year fair valu estim may differ
equiti valu per share shown due time valu money adjust case
probability-weight scenario analysi perform
fiscal year end decemb
good sold
incom equiti invest
depreci amort report separ
impair charg report separ
morningstar right reserv unless otherwis provid separ agreement may use report countri origin distributor base inform data analys opinion present herein constitut
invest advic provid sole inform purpos therefor offer buy sell secur warrant correct complet accur opinion express date written subject chang without
notic except otherwis requir law shall respons trade decis damag loss result relat inform data analys opinion use inform contain herein
proprietari properti may reproduc whole part use manner without prior written consent invest research produc issu subsidiari inc includ limit
morningstar research servic llc regist govern secur exchang commiss order reprint call licens research call pleas see import disclosur end report
